Patent | Date |
---|
RNAi Agents for Inhibiting Expression of HIF-2 alpha (EPAS1), Compositions Thereof, and Methods of Use App 20220204976 - Li; Zhen ;   et al. | 2022-06-30 |
Methods For The Treatment Of APOC3-Related Diseases And Disorders App 20220152079 - Given; Bruce D. ;   et al. | 2022-05-19 |
RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3) App 20220064646 - Li; Zhen ;   et al. | 2022-03-03 |
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3) Grant 11,214,801 - Li , et al. January 4, 2 | 2022-01-04 |
RNAi Agents And Compositions for Inhibiting Expression of Angiopoietin-Like 3 (ANGPTL3), And Methods Of Use App 20210238602 - Li; Zhen ;   et al. | 2021-08-05 |
Compositions and Methods for Inhibiting Gene Expression of Hif2alpha App 20210180066 - Wong; So ;   et al. | 2021-06-17 |
RNAi agents and compositions for inhibiting expression of angiopoietin-like 3 (ANGPTL3), and methods of use Grant 10,995,335 - Li , et al. May 4, 2 | 2021-05-04 |
Compositions and methods for inhibiting gene expression of Hif2alpha Grant 10,927,373 - Wong , et al. February 23, 2 | 2021-02-23 |
RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3) App 20200299690 - Li; Zhen ;   et al. | 2020-09-24 |
RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3) Grant 10,597,657 - Li , et al. | 2020-03-24 |
RNAi Agents And Compositions for Inhibiting Expression of Angiopoietin-Like 3 (ANGPTL3), And Methods Of Use App 20190078089 - Li; Zhen ;   et al. | 2019-03-14 |
RNAi Agents And Compositions for Inhibiting Expression of Apolipoprotein C-III (APOC3) App 20190078088 - Li; Zhen ;   et al. | 2019-03-14 |
Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo App 20190062748 - Rozema; David B. ;   et al. | 2019-02-28 |
Compositions and Methods for Inhibiting Gene Expression of Hif2alpha App 20180230470 - Wong; So ;   et al. | 2018-08-16 |
Compositions and methods for inhibiting gene expression of Hif2alpha Grant 9,976,141 - Wong , et al. May 22, 2 | 2018-05-22 |
Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo App 20170022497 - Rozema; David B. ;   et al. | 2017-01-26 |
Compositions and Methods for Inhibiting Gene Expression of Hif2alpha App 20160348107 - Wong; So ;   et al. | 2016-12-01 |
Polyconjugates for delivery of RNAi triggers to tumor cells in vivo Grant 9,487,556 - Cheng , et al. November 8, 2 | 2016-11-08 |
Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo App 20150045573 - Cheng; Weijun ;   et al. | 2015-02-12 |
Polyconjugates for in vivo delivery of polynucleotides Grant 8,658,211 - Rozema , et al. February 25, 2 | 2014-02-25 |
Polyconjugates for In Vivo Delivery of Polynucleotides App 20120230938 - ROZEMA; David B. ;   et al. | 2012-09-13 |
Polyconjugates for in vivo delivery of polynucleotides Grant 8,137,695 - Rozema , et al. March 20, 2 | 2012-03-20 |
Compounds for targeting hepatocytes Grant 7,501,394 - Sokoloff , et al. March 10, 2 | 2009-03-10 |
Formation of polyampholytes in the presence of a polyion Grant 7,470,539 - Wakefield , et al. December 30, 2 | 2008-12-30 |
Polyconjugates for In Vivo Delivery of Polynucleotides App 20080152661 - Rozema; David B. ;   et al. | 2008-06-26 |
Formation of polyampholytes in the presence of a polyion Grant 7,094,605 - Wakefield , et al. August 22, 2 | 2006-08-22 |
Compounds for targeting hepatocytes App 20060154867 - Sokoloff; Alexander V. ;   et al. | 2006-07-13 |
Compounds for targeting hepatocytes in vivo Grant 7,071,163 - Sokoloff , et al. July 4, 2 | 2006-07-04 |
Formation of polyampholytes in the presence of a polyion App 20060063257 - Wakefield; Darren H. ;   et al. | 2006-03-23 |
Formation of polyampholytes in the presence of a polyion App 20050170505 - Wakefield, Darren H. ;   et al. | 2005-08-04 |
Compounds for targeting hepatocytes in vivo App 20040029826 - Sokoloff, Alexander V. ;   et al. | 2004-02-12 |